Thoratec HeartMate II(®) left ventricular assist device implantation in patient with patent ventriculoperitoneal shunt.
نویسندگان
چکیده
We report a case of HeartMate II(®) left ventricular assist device (LVAD) implantation as a destination therapy in a patient with a patent ventriculoperitoneal (VP) shunt after being suffered from subarachnoid hemorrhage. Because the patient's VP shunt was running through her right anterior chest and abdominal wall, a driveline exit site was selected in her left upper quadrant to avoid unnecessary perioperative complication in relation to the patent VP shunt tube. Tailored driveline placement was a key element of this LVAD implantation in this already sick patient with multiple comorbidities.
منابع مشابه
Apical pseudoaneurysm following continuous flow left ventricular assist device placement.
The HeartMate II continuous flow left ventricular assist device (LVAD) (Thoratec Inc) provides circulatory support for patients with medically refractory systolic heart failure as both a bridge to transplantation and destination therapy. Although left ventricular apical pseudoaneurysm has rarely been reported with first-generation pulsatile flow LVADs, this has not been previously reported with...
متن کامل“Suction Event” in a Patient with a HeartMate II Left Ventricular Assist Device
Case Presentation: A 31 year old male with dilated cardiomyopathy and symptoms of New York Heart Association class IV heart failure presented for left ventricular assist device (LVAD) implantation as destination therapy. The patient was admitted to the hospital approximately one month prior with decompensation of his cardiomyopathy and associated liver failure. The patient was stabilized and wa...
متن کاملPercutaneous closure of a patent foramen ovale to prevent paradoxical thromboembolism in a patient with a continuous-flow LVAD.
Patent foramen ovale (PFO) may complicate left ventricular assist device (LVAD) therapy. We report a 70-year-old male with a HeartMate II LVAD at increased risk for thromboembolic stroke secondary to a PFO with right-to-left shunting and a large mobile thrombus on his right atrial pacing lead. Via percutaneous intervention, a 25 mm Cribiform Amplatzer atrial septal occluder was successfully dep...
متن کاملHemodynamic and exercise performance with pulsatile and continuous-flow left ventricular assist devices.
BACKGROUND Continuous-flow rotary pumps with axial design are increasingly used for left ventricular assist support. The efficacy of this design compared with pulsatile, volume displacement pumps, with respect to characteristics of left ventricular unloading, and exercise performance remains largely unstudied. METHODS AND RESULTS Thirty-four patients undergoing implantation with a pulsatile, ...
متن کاملOrthotopic heart transplant versus left ventricular assist device: a national comparison of cost and survival.
OBJECTIVES Orthotopic heart transplantation is the standard of care for end-stage heart disease. Left ventricular assist device implantation offers an alternative treatment approach. Left ventricular assist device practice has changed dramatically since the 2008 Food and Drug Administration approval of the HeartMate II (Thoratec, Pleasanton, Calif), but at what societal cost? The present study ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- Annals of thoracic and cardiovascular surgery : official journal of the Association of Thoracic and Cardiovascular Surgeons of Asia
دوره 18 4 شماره
صفحات -
تاریخ انتشار 2012